Hesperos Inc.
Mridu Malik is a scientist with extensive experience in biomedical engineering and research. Currently serving as Scientist I and Barrier Tissue Team Lead at Hesperos Inc. since January 2022, responsibilities include the development of multi-organ microphysiological systems, characterization of iPSC-derived barrier tissue models, and management of a team of research associates. Prior roles include Postdoctoral Associate at the National Institute of Standards and Technology, focusing on 3D microphysiological systems for drug toxicity screening, and Graduate Research Assistant at Binghamton University, where research centered on the gut-microbiome model and intestinal health. Mridu Malik holds a PhD and MS in Biomedical Engineering from Binghamton University and a B.Tech in Biotechnology from Amity University.
Hesperos Inc.
Hesperos, Inc. is a leader in efforts to characterize an individual's biology with Human-on-a-Chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organsystems. With a mission to revolutionize toxicology testing as well as efficacy evaluation for drug discovery, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational PKPD modeling of live physiological responses utilizing functional readouts from neurons, cardiac, muscle, barrier tissues and neuromuscular junctions as well as responses from liver, pancreas and barrier tissues.